Skip to main content
High RiskFDAfda-F-2017-2014UNDECLARED ALLERGEN

El Original pa' ya To Go by hot pandeyuca brand Small Cheese Bread Quesipan

Category
Units Affected
1,651
Recall Date
March 21, 2014
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2017-2014.

During an FDA inspection, it was discovered that the label of several products failed to declare the components ingredients of a butter flavor that included allergens FD&C Yellow #5, FD&C Yellow #6 and FD&C Red #40.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2017-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Hot Pandeyuca & Company Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2017-2014.

Hot Pandeyuca & Company Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Hot Pandeyuca & Company Inc Recall FAQ

Hot Pandeyuca & Company Inc is the subject of a dairy safety report: El Original pa' ya To Go by hot pandeyuca brand Small Cheese Bread Quesipan. The notice was published on March 21, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 1,651 units are potentially affected.